Professur für Translationale Frauenheilkunde und Geburtshilfe

Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics (2018) Poehls UG, Hack C, Ekici AB, Beckmann M, Fasching P, Rübner M, Hübner H Journal article Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility (2018) Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, et al. Journal article Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data (2018) Wunderle M, Olmes G, Nabieva N, Häberle L, Jud S, Hein A, Rauh C, et al. Journal article Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy (2018) Denkert C, Von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, Budczies J, et al. Journal article Effects of prenatal alcohol consumption on cognitive development and ADHD-related behaviour in primary-school age: a multilevel study based on meconium ethyl glucuronide (2018) Eichler A, Hudler L, Grunitz J, Grimm J, Raabe E, Goecke TW, Fasching P, et al. Journal article Associations of prenatal depressive symptoms with DNA methylation of HPA axis-related genes and diurnal cortisol profiles in primary school-aged children (2018) Stonawski V, Frey S, Golub Y, Rohleder N, Kriebel J, Goecke TW, Fasching P, et al. Journal article, Original article Standard Changing News der Senologie und Gynäkologischen Onkologie (2017) Rauh C, Jud S, Hein A, Hack C, Fasching P, Beckmann M, Lux MP Journal article Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients (2017) Hartkopf AD, Graf J, Simoes E, Keilmann L, Sickenberger N, Gaß P, Wallwiener D, et al. Journal article Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy (2017) Kolberg HC, Loevey G, Akpolat-Basci L, Stephanou M, Fasching P, Untch M, Liedtke C, et al. Journal article Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study (2017) Higgins M, Curigliano G, Dieras V, Kuemmel S, Kunz G, Fasching P, Campone M, et al. Journal article